Parallel Health joins Aetna network in California for microbiome dermatology access

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Parallel Health, a predictive precision health company pioneering Microbiome Dermatology™, is now in-network with Aetna in California, enabling Aetna members in the state to access the company’s MD-03 Protocol™ with reduced monthly costs, the company said. The MD-03 Protocol™ uses advanced microbial genomic analysis and AI-driven insights to customise treatments for a range of skin conditions based on each patient’s unique skin microbiome profile.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Evommune bets $30m upfront on a new autoimmune drug

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE